Clinical Features, Biochemical Parameters, and Treatment Adherence of Individuals Who Started the Treatment for Active Pulmonary Tuberculosis during the Pandemic Period.

Autor: Sales, Amanda Caroline de Souza, Lopes, Larissa Araújo, Vale, Maria Caroliny dos Santos, Costa, Mayara Ferreira, Lima, João Victor de Souza, Silva, João Gabriel Matos da, Ferreira, Bruna Sthefanny da Cunha, Nascimento, Victoria Alves do, Flor, Saara Emanuele da Silva, Sousa, Elane Luiza Costa de, Paz, Bruna Katarine Bezerra, Garcia, Ricardo Amorim de Sousa, Sousa, Eduardo Martins de, Santos, Alexsandro Ferreira dos, Silva, Luís Cláudio Nascimento da, Zagmignan, Adrielle
Předmět:
Zdroj: Journal of Clinical Medicine; Jul2023, Vol. 12 Issue 14, p4843, 15p
Abstrakt: This descriptive prospective study investigated the clinical features and treatment adherence of individuals who started the treatment for Pulmonary tuberculosis (TB) during the COVID-19 pandemic in São Luís. Thirty-six TB patients and thirty-five age/sex-matched individuals were recruited between January 2021 and January 2022. The clinical features, sociodemographic information, and serum were obtained at the diagnosis time. Adherence to treatment and adverse reactions were investigated monthly. The most common symptoms in TB patients were cough (91.6%) and fever (83.3%). All TB patients had elevated pre-therapy levels of CRP and reduced HDL: 88.9% presented hypocalcemia and 47.2% showed elevated ALP and GGT. TB patients showed higher levels of ALT, AST, ALP, GGT, CRP, amylase, and triglycerides than the comparison group (p < 0.05), while the calcium levels were reduced (p < 0.0001). TB patients with anti-SARS-CoV-2-IgG antibodies (seroprevalence of 66.7%) presented higher values of amylase and lower CRP levels (p < 0.05). Most patients (~70%) reported at least one adverse drug reaction, mainly pruritus and nausea. The treatment abandonment rate was 19.2%. In conclusion, TB patients showed elevated pre-therapy levels of CRP, low levels of HDL, and hypocalcemia. Liver and pancreatic functions were also compromised in several patients before the therapy. The treatment non-adherence rate observed was similar to other studies performed before the pandemic period. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje